We are live on ! Find out more
QC

Quantessence Capital Portfolio holdings

AUM $20.5M
1-Year Est. Return 71.02%
This Fund
S&P 500
This Quarter Est. Return
+14.43%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$60.2M
Cap. Flow
-$87.3M
Cap. Flow %
-25.71%
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302

Top Buys

Rank Stock Value
1
AZEK
The AZEK Co
AZEK
+$58.6M
2
RDFN
Redfin
RDFN
+$35.6M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.53M
4
SFM icon
Sprouts Farmers Market
SFM
+$7.45M
5
INSM icon
Insmed
INSM
+$5.79M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$30.3M
2
XLC icon
State Street Communication Services Select Sector SPDR ETF
XLC
+$12.3M
3
XOM icon
ExxonMobil
XOM
+$11.3M
4
BECN
Beacon Roofing Supply, Inc.
BECN
+$10.8M
5
PFE icon
Pfizer
PFE
+$10.6M

Sector Composition

Rank Sector Weight
1 Industrials 31.47%
2 Real Estate 13.23%
3 Healthcare 10.04%
4 Financials 9.26%
5 Consumer Discretionary 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCTH icon
251
Delcath Systems
DCTH
$429M
– –
-17,330
Closed -$221K
DHI icon
252
D.R. Horton
DHI
$41B
– –
-2,025
Closed -$257K
DKS icon
253
Dick's Sporting Goods
DKS
$18.4B
– –
-5,800
Closed -$1.17M
DLTR icon
254
Dollar Tree
DLTR
$23.1B
– –
-14,433
Closed -$1.08M
DNA icon
255
Ginkgo Bioworks
DNA
$498M
– –
-30,550
Closed -$174K
DNOW icon
256
DNOW Inc
DNOW
$2.63B
– –
-19,600
Closed -$335K
DOUG icon
257
Douglas Elliman
DOUG
$159M
– –
-29,292
Closed -$50.4K
DOX icon
258
Amdocs
DOX
$5.58B
– –
-9,100
Closed -$833K
DTE icon
259
DTE Energy
DTE
$31.2B
– –
-4,300
Closed -$595K
EARN
260
Ellington Residential Mortgage REIT
EARN
$166M
– –
-21,208
Closed -$115K
EBS icon
261
Emergent Biosolutions
EBS
$377M
– –
-43,817
Closed -$213K
EHTH icon
262
eHealth
EHTH
$43.8M
– –
-17,910
Closed -$120K
ELDN icon
263
Eledon Pharmaceuticals
ELDN
$279M
– –
-16,523
Closed -$56K
EMR icon
264
Emerson Electric
EMR
$83.1B
– –
-13,600
Closed -$1.49M
ENOV icon
265
Enovis
ENOV
$1.56B
– –
-17,013
Closed -$650K
EOSE icon
266
Eos Energy Enterprises
EOSE
$1.26B
– –
-140,740
Closed -$532K
EQH icon
267
Equitable Holdings
EQH
$13.1B
– –
-42,802
Closed -$2.23M
ETON icon
268
Eton Pharmaceutcials
ETON
$1.19B
– –
-16,590
Closed -$215K
EXFY icon
269
Expensify
EXFY
$172M
– –
-40,000
Closed -$122K
AGNT
270
AGNT Inc
AGNT
$670M
– –
-15,700
Closed -$154K
FCNCA icon
271
First Citizens BancShares
FCNCA
$25.1B
– –
-150
Closed -$278K
FDX icon
272
FedEx
FDX
$75.1B
– –
-3,600
Closed -$878K
FFIV icon
273
F5
FFIV
$22B
– –
-1,200
Closed -$320K
FIS icon
274
Fidelity National Information Services
FIS
$21.6B
– –
-10,300
Closed -$769K
FLGT icon
275
Fulgent Genetics
FLGT
$569M
– –
-10,100
Closed -$171K
9 10
11
12 13

Similar funds

FS
Financially Speaking Greenwood Village, Colorado $20.6M AUM 24.93% 1-Year Est. Return
BC
Bakala Capital Greenville, South Carolina $20.8M AUM 13.01% 1-Year Est. Return
LFA
LGT Financial Advisors Dallas, Texas $19.5M AUM 22.6% 1-Year Est. Return
HAM
Honeycomb Asset Management New York $19.4M AUM 25.86% 1-Year Est. Return
DP
Declaration Partners New York $21.8M AUM
SPC
Stone Point Capital Greenwich, Connecticut $21.9M AUM 47.18% 1-Year Est. Return
IW
Imprint Wealth Mount Pleasant, South Carolina $21.9M AUM
SRHG
Stone Ridge Holdings Group New York $19M AUM 8.85% 1-Year Est. Return

Quantessence Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Quantessence Capital held 483 positions worth $340M, down 15% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Quantessence Capital withdrew a net $87.3M in Q2 2025, closing 302 positions and reducing 18 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 11% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Quantessence Capital opened a new position in The AZEK Co worth $63.6M.

  • Quantessence Capital's largest Q2 2025 buy was The AZEK Co: 1,170,131 shares worth $63.6M.
  • Quantessence Capital added most to Merck in Q2 2025, an estimated $3.19M increase.
  • Quantessence Capital's biggest Q2 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $1.84M.
  • Quantessence Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $30.3M.
  • Quantessence Capital's ten largest holdings make up 46% of its $340M portfolio in Q2 2025.
  • Quantessence Capital opened 151 new positions and closed 302 in Q2 2025.
  • Quantessence Capital's portfolio value fell 15% quarter-over-quarter to $340M.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.